Drug profile

The FDA adverse-event record for Cleansing Solution

16 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Cleansing Solution. See the species affected, top reactions, and outcomes below.

16
adverse-event reports
12.5%
death-coded share
Dog
most-reported species
4
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
16
Total Reports
2
Deaths Reported
12.5%
Death Rate

Active Ingredients

Cleansing Solution

Administration Routes

Auricular (Otic)TopicalUnknownOral

Species Affected

Dog 11
Cat 5

Most Affected Breeds

Chihuahua 3
Domestic Shorthair 2
Retriever - Golden 2
Bengal 2
Spaniel (unspecified) 1
Terrier - Rat 1
Alaskan Malamute 1
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 1
Domestic Mediumhair 1
Retriever - Labrador 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 4
Ataxia 3
Balance problem 3
Vomiting 2
Anaphylaxis 2
Unable to stand 2
Lack of efficacy - NOS 2
Bacterial skin infection NOS 2
Wound 2
Eye pain 2
Squinting 2
Ocular discharge 2

Outcome Breakdown

Outcome Unknown
6 (37.5%)
Ongoing
5 (31.3%)
Recovered/Normal
3 (18.8%)
Died
2 (12.5%)

Cleansing Solution Adverse Event Insights

16 reports name Cleansing Solution; 2 recorded a death outcome (12.5% of reported events, not a population-level mortality rate). Active ingredient: Cleansing Solution. Administration routes: Auricular (Otic), Topical, Unknown, Oral.

By species: Dog (11 reports), Cat (5 reports). By breed: Chihuahua (3), Domestic Shorthair (2), Retriever - Golden (2).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (4), Ataxia (3), Balance problem (3), Vomiting (2). Outcome, 16 coded reports: Outcome Unknown leads at 37.5%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.